[go: up one dir, main page]

AU2003271457A1 - Methods for detecting prostate cancer - Google Patents

Methods for detecting prostate cancer

Info

Publication number
AU2003271457A1
AU2003271457A1 AU2003271457A AU2003271457A AU2003271457A1 AU 2003271457 A1 AU2003271457 A1 AU 2003271457A1 AU 2003271457 A AU2003271457 A AU 2003271457A AU 2003271457 A AU2003271457 A AU 2003271457A AU 2003271457 A1 AU2003271457 A1 AU 2003271457A1
Authority
AU
Australia
Prior art keywords
methods
prostate cancer
detecting prostate
detecting
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003271457A
Other versions
AU2003271457A8 (en
Inventor
Eleftherios P. Diamandis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mt Sinai Hospital
Original Assignee
Mt Sinai Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mt Sinai Hospital filed Critical Mt Sinai Hospital
Publication of AU2003271457A8 publication Critical patent/AU2003271457A8/en
Publication of AU2003271457A1 publication Critical patent/AU2003271457A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003271457A 2002-09-26 2003-09-26 Methods for detecting prostate cancer Abandoned AU2003271457A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41431402P 2002-09-26 2002-09-26
US60/414,314 2002-09-26
PCT/CA2003/001479 WO2004029616A2 (en) 2002-09-26 2003-09-26 Methods for detecting prostate cancer

Publications (2)

Publication Number Publication Date
AU2003271457A8 AU2003271457A8 (en) 2004-04-19
AU2003271457A1 true AU2003271457A1 (en) 2004-04-19

Family

ID=32043380

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003271457A Abandoned AU2003271457A1 (en) 2002-09-26 2003-09-26 Methods for detecting prostate cancer

Country Status (4)

Country Link
EP (1) EP1546729A2 (en)
AU (1) AU2003271457A1 (en)
CA (1) CA2498147A1 (en)
WO (1) WO2004029616A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10568869B2 (en) 2012-12-11 2020-02-25 Cornell University Methods for diagnosing and treating prostate cancer
CN113866412B (en) * 2021-09-07 2024-07-26 山东博科生物产业有限公司 Sensitive total prostate specific antigen detection kit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040203012A1 (en) * 2001-05-25 2004-10-14 Eleftherios Diamandis Method of detecting and monitoring prostate and ovarian cancers

Also Published As

Publication number Publication date
AU2003271457A8 (en) 2004-04-19
CA2498147A1 (en) 2004-04-08
WO2004029616A2 (en) 2004-04-08
WO2004029616A3 (en) 2004-07-15
EP1546729A2 (en) 2005-06-29

Similar Documents

Publication Publication Date Title
AU2003294205A1 (en) Prostate cancer biomarkers
AU2003294828A1 (en) Specific markers for pancreatic cancer
AU2009210417A1 (en) Method of detecting thyroid cancer
AUPS054702A0 (en) Cancer therapy
AU2003263611A1 (en) Method for diagnosing prostate cancer
AU2003271456A1 (en) Methods for detecting endocrine cancer
AU2003269618A1 (en) Methods for detecting breast and ovarian cancer
AU2003213960A1 (en) Methods for detecting ovarian cancer
AU2003235749A1 (en) Biomarkers for detecting ovarian cancer
AU2002307466A1 (en) Method for detecting breast cancer cells
AU2003231084A1 (en) Identification of biomarkers for detecting prostate cancer
WO2002087504A9 (en) Methods for inhibiting tumor cell proliferation
AU2003224598A1 (en) Differentially-regulated prostate cancer genes
AU2003256995A1 (en) Method for identifying cancer risk
AU2003202205A1 (en) Methods for identifying cancer risk
AU2003276973A1 (en) Detection methods
AU2003264488A1 (en) Immunotherapeutic for cancer
AU2002258597A1 (en) Prognostic methods for breast cancer
AU2003272964A1 (en) Remedy for hormone-dependent cancer
AU2003232532A1 (en) Method for mobile payment
AU2003278211A1 (en) Methods for detection of genetic alterations associated with cancer
AU2003287564A1 (en) Methods of detecting colorectal cancer
AU2003212826A1 (en) Cancer genes
AU2003283339A1 (en) Cancer therapy determination
AU2003271457A1 (en) Methods for detecting prostate cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase